AstraZeneca toAcquire 55% Stake in Acerta for Upfront Payment of $2.5B By: Benzinga via Benzinga December 17, 2015 at 05:30 AM EST Acerta Pharma B.V. (Acerta), a clinical-stage biopharmaceutical company, announced today that it has entered into a ... Read More >> Related Stocks: Astrazeneca Plc ADR Macy's